6 Secrets of Ivermectin: The Medication That Keeps on Giving

And dirty little secrets of the failed and dangerous medication that Merck promoted instead — Molnupiravir.

Greetings Dear Colleagues,

Inspired by my recent podcast with my friend Dr. Kory (who must be considered the world’s expert on the use of Ivermectin in COVID), I wanted to share some summary insights about this truly amazing medication with you.

I like to refer to it as “The People’s Medicine.” Why? Consider it for yourself.

From its humble beginnings in a soil sample near a golf course in Japan (NB: still the only place in the world where it has been discovered), this little natural medicine has benefited human health like few others in history. Before COVID, the Nobel Prize committee called it a “wonder drug” and “a splendid gift from the earth” for good reason.

We know it won the Nobel Prize in Medicine in 2015 for curing disfiguring parasitic diseases like elephantiasis and river blindness; we know it is on the WHO list of “essential medicines”; and we know it prevents COVID and saves lives through multiple mechanisms.

Technical review article outlining the various ways it combats COVID.
All trials’ meta-data in one place
But all of this is fairly well-known; I’d like to go beyond COVID and add value to the discussion by drawing your attention to all of the other ways I believe this is truly a miracle medication.

1. It revolutionized veterinary medicine and arguably stabilized the world’s food supply.

When it was first introduced in 1981, it quickly became the best-selling veterinary medicine in the world, thanks to its ability to kill parasites both internally and externally. The benefits range from saving Lassie from heart worms.

.. all the way to eradicating parasites in cattle, pigs, sheep and goats. (And in this latter capacity, it can be argued to have contributed significantly to stabilizing world livestock numbers/food supply.)

2. It’s active against the FLU and RSV.

Because it inhibits flu and RSV viral replication, it is included in the FLCCC flu and RSV protocols.

It’s also effective against Zika, Dengue, West Nile Virus, Yellow Fever, and HIV (read more about it).

3. It reduces inflammation throughout the body.

I raised an eyebrow when a patient told me, “I took Ivermectin and my hip arthritis felt better,” or “Ivermectin helped my back pain.” Then I did some research and discovered that Ivermectin has systemic anti-inflammatory properties (it inhibits TNF-alpha, IL-6, and NF-kB).

So when a patient told me, “I rubbed topical Ivermectin on my eczema patches and it did wonders,” I smiled knowingly. (There’s nothing like being informed!)

4. Improves the gastrointestinal microbiome by boosting levels of the probiotic Bifidobacterium.

Dr. Sabine Hazan’s research led to this discovery.

But hold on! There’s even more!

5. May help with athletic and sports performance by boosting cellular energy output in the heart.

What if I told you that Ivermectin allows heart muscle cells to produce energy more efficiently — even when oxygen levels are low (as during intense exercise)? You can read all about it here.

Because it works this way in heart cells, it is possible that it will work the same way in all cells. (To put it in scientific jargon, “Ivermectin increased mitochondrial ATP production by inducing Cox6a2, a subunit of the mitochondrial respiratory chain.”)

Not surprisingly, I recall hearing an anecdote from eminent COVID scientist Geert Vanden Bossche Ph.D (who began his career as a veterinarian) relating that racehorses given Ivermectin appeared to run faster. (No one knew why at the time.)

And now… drumroll please… The grand finale; the pinnacle; the apogee; the zenith; the ne plus ultra of this extraordinary medicine.

6. It has profound anti-cancer properties.

How profound is that? Take a look at the following:

Overcomes chemotherapy resistance in cancer cells (read more here)
Inhibits the growth of more than 70% of all cancers by inhibiting a protein (PAK1).
Multiple anti-breast cancer mechanisms of action (read more here)

Molnupiravir: “That Dog Don’t Hunt”

Let us now turn our attention to a quote from the founder of Merck, the illustrious company that invented and commercialized Ivermectin…

“We try never to forget that medicine is for the people,” says George Merck. It’s not just about the money.”

Brother, yes!! I guess current management didn’t get the memo, because when presented with preliminary evidence of its potential against COVID, Merck stubbornly refused to pursue further research, preferring to pump its own, patented, outpatient treatment — Molnupiravir. Which turns out to have a fascinating backstory:

• Developed by Pharmasset, a pharmaceutical company that abandoned it in 2003 after discovering its mutagenic (“cancer-promoting”) properties. (Read more here)
• Emory University then picked it up, securing 26 million dollars in taxpayer grants from the NIH and DOD and making a few changes. (Read more here)
• The rights were then purchased by a flimsy, stand-in “biotechnology” company run by hedge fund managers, who promptly turned around and up-sold it to Merck (after securing the rights to hundreds of millions of dollars in future profits). (Read more here)
• Before it was even approved, he pitched it to the US government and secured a 2.2 billion dollar purchase guarantee. (Read more here).
• It was then narrowly approved by the FDA’s independent safety review panel (13 votes in favor, 10 votes against). (Read more here) because…
• It causes mutations in the virus’s genome; could it also do so in the human genome? Hmmm. Nobody is aware.
• All of this prompted a federal whistleblower to come forward and blow the whistle. (Read more here) The FDA ignored this and proceeded with emergency authorization based on a single study that was terminated early (cue the 2.2 billion dollar “Cha-Ching” sounds in the background).
• In that study, how effective was it? Within this time period, 6.8% of the 709 people who received Molnupiravir were hospitalized or died, compared to 9.7% of the 699 people who received a placebo.
• In simple terms: If you gave a sugar pill to 100 COVID patients, 10 would end up in the hospital or dead; if you gave the same group Molnupiravir, 7 would still end up in the hospital or dead. So, in 3 out of 100 people, the drug makes a difference compared to doing nothing. (Read more here)
• Which was so underwhelming that the British Medical Journal openly criticized it. (Read more here) This influenced the British National Institute for Health and Care Excellence to add it to its “not recommended list” (where it joined Remdesivir), after research revealed that it made no significant difference in hospitalization or death rates and was not cost-effective. (Read more here)
• What do you think, folks? “Are you not entertained?!” (From the film Gladiator).This stuff isn’t made up.

All of this is very interesting because when you compare Molnupiravir to Ivermectin, you can see what a disgraceful, overpriced stink-bomb it is:

Ivermectin: 62% improvement, 99 studies, $1 per pill

Merck’s Show Pony: 15% improvement, 34 studies, $707 per pill

Or check this chart:

Ivermectin: $24 to save 1 life from COVID

Merck’s loud, obnoxious, hot rod with flashy rims that barely runs: $137,653 to save 1 life from COVID

And with that, my friends, we come to the end of our story. Ivermectin: a historical chapter with as much pathos as a Shakespearean tragedy, as much subterfuge and intrigue as the best Le Carre spy novel, and as much determination, honor, and righteous indignation as the grittiest Clint Eastwood Western…And it’s still being worked on. “Power to The People.”

Do you fancy some?